Antidiabetic agents: past, present and future.

Antidiabetic agents: past, present and future.

Item
http://www.wikidata.org/entity/Q38089737
Loss of the anorexic response to systemic 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside administration despite reducing hypothalamic AMP-activated protein kinase phosphorylation in insulin-deficient rats.Managing diabetes with nanomedicine: challenges and opportunitiesEvaluation of ranirestat for the treatment of diabetic neuropathy.Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus.α-Glucosidase inhibitory activity and cytotoxic effects of some cyclic urea and carbamate derivatives.Phosphatidic acid: a new therapeutic lead to suppress hepatic glucose production.Relieving the cardiometabolic disease burden: a perspective on phytometabolite functional and chemical annotation for diabetes management.Synthetic agents in the context of metabolic/bariatric surgery: expanding the scope and impact of diabetes drug discovery.Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus.The importance of drug discovery for treatment of cardiovascular diseases.
P2860

Antidiabetic agents: past, present and future.

Item
http://www.wikidata.org/entity/Q38089737
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antidiabetic agents: past, present and future.
@en
type
label
Antidiabetic agents: past, present and future.
@en
prefLabel
Antidiabetic agents: past, present and future.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Antidiabetic agents: past, present and future.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698